STOCKHOLM, August 25, 2021 /PRNewswire/ — Elekta AB (publ) held its annual general meeting on August 25, 2021. Given the exceptional situation prevailing due to Covid-19, the Meeting was held by early postal vote, without physical presence. A statement from the CEO and Chairman as well as an interview with the Chairman of the Board of Directors are available on the Elekta website, www.elekta.com.
Meeting documents with full details of all resolutions are also available on the website. A summary of the resolutions taken by the Assembly follows.
Accounting documents and disclaimer
The directors, the Chairman and Chief Executive Officer have been relieved of their responsibility for the 2020/21 financial year after the adoption of the income statements and balance sheets of the parent company and the group.
Dividend and disposal of Company profits
The Meeting decided on a dividend corresponding to SEK2.20 per share and the remaining earnings are deferred. The dividend is divided into two installments of SEK1.10 by payment.
The first record day is Friday August 27, 2021. The second record day is Monday February 28, 2022. The dividend should be paid on Wednesday September 1, 2021 and Thursday March 3, 2022 respectively.
Board of Directors and Committees
The Meeting decided that the number of directors will be seven without alternates. All directors were re-elected. Laurent Leksell was re-elected Chairman of the Board.
The Meeting decides that the remuneration of the Board of Directors will be increased compared to the previous year, in accordance with the proposal of the Board of Directors.
Ernst & Young AB, with the authorized auditor Rickard Anderssonhas been re-elected as Company Commissioner for the period until the end of the next Annual General Meeting and the fees of the Commissioner will be paid in accordance with the approved invoice.
The remuneration report of the Board of Directors
The Meeting approved the remuneration report of the Board of Directors on remuneration.
2021 performance share plan
The Meeting voted on the implementation of the 2021 Performance Share Plan in accordance with the proposal of the Board of Directors, and on the sale of treasury shares due to the 2021 Performance Share Plan.
The program includes the President and CEO, senior management and named key contributors, in total approximately 25 employees, who will qualify for the free award of Series B shares of Elekta after the expiration of the period of three years and conditional on continuous employment in the Group until the end of the 2023/2024 Performance Year. The maximum number of shares that can be granted depends on the degree of achievement of a performance objective, the total shareholder return (“TSR”) of Elekta compared to the OMXS30 index over a three-year period. For the 2021 Performance Share Plan, the minimum performance requirement is that Elekta TSR outperforms the OMXS30 index by at least +0.1%. The maximum performance level requires Elekta TSR to outperform the OMXS30 index at or above +15%. The performance target will be adjusted upon the occurrence of events affecting the number of outstanding shares of the Company, or unforeseen material events affecting the operations of the Elekta Group or otherwise affecting the performance target and deemed relevant by the Board of Directors. In the event of a change in accounting principles or if the Company decides on restructuring costs, the Board of Directors may decide to modify the performance objective of the 2021 Performance Share Plan.
Assuming a maximum allocation under the 2021 Performance Share Plan and a share price of SEK114.6, a maximum of 604,097 Series B shares are required to fulfill program commitments (including payroll taxes), corresponding to approximately 0.16% of the total number of shares outstanding. Under the assumptions above, the costs, including social charges and the cost of financing the own shares repurchased, are estimated at approximately SEK 69,229,533.
Acquisition and transfer of own shares
The Meeting authorized the Board of Directors, in accordance with the proposal of the Board of Directors, during the period until the next Annual General Meeting, to decide, on one or more occasions, the acquisition of a total number of Series B treasury stock so that, after the purchase, the Company does not hold more than ten percent of the total number of shares of the Company. In addition, the Meeting authorized the Board of Directors, in accordance with the proposal of the Board of Directors, during the period until the next Annual General Meeting, to decide, on one or more occasions, the transfer of shares Series B shares in conjunction with the financing of corporate acquisitions and other types of strategic investments and acquisitions, and not exceeding the maximum number of treasury shares held by the Company at any given time.
Given the 2021 Performance Share Plan, the Meeting decided, in accordance with the proposal of the Board of Directors, that a maximum of 1,000,000 series B shares may be transferred with derogation from the preferential right of shareholders, and to authorize the Board of Directors, until the next Annual General Meeting to decide, on one or more occasions, the transfer of a maximum of 467,559 own shares of series B on the Nasdaq Stockholm to cover certain expenses, mainly social security contributions.
Contribution to create a philanthropic foundation
The Meeting decided on a contribution by the Company of an amount of up to SEK 35,000,000 as initial foundation capital for the purpose of establishing a philanthropic foundation of the Society, with the aim of improving access to and quality of cancer care with a particular focus on radiotherapy.
For more information, please contact:
Cecilia KetelsHead of Investor Relations
Tel: +46 76 611 76 25, e-mail: [email protected]
Time zone: CET: Central European Time
The information has been submitted for publication to 2:00 p.m. CEST on August 25, 2021. (REGMAR)
For nearly five decades, Elekta has been a leader in precision radiation therapy. Our more than 4,400 employees worldwide are committed to ensuring that everyone with cancer around the world has access to – and benefits from – more precise and personalized radiation therapy treatments. Based at stockholm, Sweden, Elekta is listed on the NASDAQ Stockholm Exchange. To visit elekta.com or follow @Elekta on Twitter.
This information was brought to you by Cision http://news.cision.com
The following files are available for download: